Skip to content
10-Q

Quarterly Report

XTANT MEDICAL HOLDINGS, INC. XTNT

0001641172-25-009674

← back to feed
Filed
May 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 9, 2025 139.32M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $22.17M
Long Term Debt Q1 2025 · Dec 31, 2024 $22.04M
Current Liabilities Q1 2025 · Mar 31, 2025 $29.58M
Current Liabilities Q1 2025 · Dec 31, 2024 $28.58M
Total Liabilities Q1 2025 · Mar 31, 2025 $51.96M
Total Liabilities Q1 2025 · Dec 31, 2024 $50.87M
Current Assets Q1 2025 · Mar 31, 2025 $69.14M
Current Assets Q1 2025 · Dec 31, 2024 $67.12M
Total Assets Q1 2025 · Mar 31, 2025 $95.83M
Total Assets Q1 2025 · Dec 31, 2024 $93.84M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $6.2M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $4.55M
Shares Diluted Q1 2025 · Mar 31, 2024 130.2M sh
Capex Q1 2025 · Mar 31, 2024 $773K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$5.76M
Stockholders Equity Q1 2025 · Mar 31, 2024 $47.68M
Stockholders Equity Q1 2025 · Dec 31, 2023 $51.35M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.03
Eps Basic Q1 2025 · Mar 31, 2024 −$0.03
Sga Expense Q1 2025 · Mar 31, 2024 $7.79M
Rd Expense Q1 2025 · Mar 31, 2024 $527K
Net Income Q1 2025 · Mar 31, 2024 −$4.4M
Operating Income Q1 2025 · Mar 31, 2024 −$3.47M
Gross Profit Q1 2025 · Mar 31, 2024 $17.3M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $10.57M
Revenue Q1 2025 · Mar 31, 2024 $27.87M